Akèy › Kansè tete negatif triple › Washington › Tacoma
Etid klinik pou Kansè tete negatif triple nan Tacoma, WA
3 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Tacoma (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Ap rekriteFaz 3
- Northwest Medical Specialties, PLLC ( Site 0093), Tacoma
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Ap rekriteFaz 3
- Northwest Medical Specialties, PLLC ( Site 0067), Tacoma
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Ap rekriteFaz 3
- MultiCare Regional Cancer Center - Tacoma, Puyallup · 8 mi lwen
- Northwest Medical Specialties, PLLC, Puyallup · 8 mi lwen
- Providence Regional Cancer System, Lacey · 23 mi lwen
Etid Kansè tete negatif triple nan lòt vil
- Houston, TX42 etid
- New York City, NY31 etid
- Nashville, TN28 etid
- Los Angeles, CA27 etid
- Boston, MA26 etid
- San Antonio, TX23 etid
- St. Louis, MO21 etid
- Arlington, VA20 etid
- Atlanta, GA20 etid
- Dallas, TX18 etid
- Chicago, IL16 etid
- Columbus, OH16 etid
Lòt etid nan Tacoma
- Kansè Poumon ki pa ti selil20 etid
- Kansè nan tete18 etid
- Kolit Ulseratif15 etid
- Myelom Miltip13 etid
- Kansè pwostat11 etid
- Maladi Crohn11 etid
- Kansè kolorektal9 etid
- Kansè Metastatik9 etid
- Melanom7 etid
- Kansè ovè7 etid
- Kansè lestomak6 etid
- Kansè Ezofajyen6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.